Posaconazole Tablet
Product Images NDC 62135-429

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 62135-429). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Posaconazole Dr 100mg Bottle Label)

Label for Posaconazole Delayed-Release Tablets, 100 mg strength, oral dosage form. The label states the tablets are prescription only, supplied by Chartwell RX with a package count of 60 tablets. Storage instructions and a note about non-interchangeability with the oral suspension are included, along with a barcode and manufacturer information for Chartwell RX, LLC.*

FDA Label Image

Image Description (Posaconazole Dr Structure)

Chemical structure of Posaconazole, the active ingredient in Posaconazole Delayed-Release tablets 100 mg by Chartwell RX, LLC. The structure depicts the molecular layout including fluorinated aromatic rings and triazole moieties characteristic of this antifungal agent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.